Patterns of Palliation: A Review of Casualties That Received Pain Management Before Reaching Role 2 in Afghanistan
Military Medicine · 2023
DOI: 10.1093/milmed/usac211 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Military Medicine, 2023. Verfasst von Ian L Hudson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brooke Army Medical Center, San Antonio, TX 78234, USA. Hauptthemen laut MEDLINE: Ketamine, Military Medicine, Emergency Medical Services, Wounds and Injuries. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Defense Medical Research and Development Program.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Introduction
Battlefield pain management changed markedly during the first 20 years of the Global War on Terror. Morphine, long the mainstay of combat analgesia, diminished in favor of fentanyl and ketamine for military pain control, but the options are not hemodynamically or psychologically equivalent. Understanding patterns of prehospital analgesia may reveal further opportunities for combat casualty care improvement. Materials and Methods Using Department of Defense Trauma Registry data for the Afghanistan conflict from 2005 to 2018, we examined 2,402 records of prehospital analgesia administration to assess temporal trends in medication choice and proportions receiving analgesia, including subanalysis of a cohort screened for an indication with minimal contraindication for analgesia. We further employed frequency matching to explore the presence of disparities in analgesia by casualty affiliation.
Results
Proportions of documented analgesia increased throughout the study period, from 0% in 2005 to 70.6% in 2018. Afghan casualties had the highest proportion of documented analgesia (53.0%), versus U.S. military (31.9%), civilian/other (23.3%), and non-U.S. military (19.3%). Fentanyl surpassed morphine in the frequency of administration in 2012. The median age of those receiving ketamine was higher (30 years) than those receiving fentanyl (26 years) or nonsteroidal anti-inflammatory drugs (23 years). Among the frequency-matched subanalysis, the odds ratio for ketamine administration with Afghan casualties was 1.84 (95% CI, 1.30-2.61).
Conclusions
We observed heterogeneity of prehospital patient care across patient affiliation groups, suggesting possible opportunities for improvement toward an overall best practice system. General increase in documented prehospital pain management likely reflects efforts toward complete documentation, as well as improved options for analgesia. Current combat casualty care documentation does not include any standardized pain scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brooke Army Medical Center, San Antonio, TX 78234, USA.
- US Army Institute of Surgical Research, San Antonio, TX 78234, USA.
- The Geneva Foundation, San Antonio, TX 78234, USA.
ORCID-Profile: Ian L Hudson, Amanda M Staudt, Carmen Hinojosa-Laborde, Steven G Schauer, Christopher A VanFosson
Förderung
- Defense Medical Research and Development Program
Zitieren
APA
Hudson, I. L., Staudt, A. M., Burgess, M., Hinojosa-Laborde, C., Schauer, S. G., Newberry, R. K., Ryan, K. L., & VanFosson, C. A. (2023). Patterns of Palliation: A Review of Casualties That Received Pain Management Before Reaching Role 2 in Afghanistan. Military Medicine. https://doi.org/10.1093/milmed/usac211
Vancouver
Hudson IL, Staudt AM, Burgess M, Hinojosa-Laborde C, Schauer SG, Newberry RK, et al. Patterns of Palliation: A Review of Casualties That Received Pain Management Before Reaching Role 2 in Afghanistan. Military Medicine. 2023. doi:10.1093/milmed/usac211
BibTeX
@article{Hudson2023,
author = {Hudson, Ian L and Staudt, Amanda M and Burgess, Matthew and Hinojosa-Laborde, Carmen and Schauer, Steven G and Newberry, Ryan K and Ryan, Kathy L and VanFosson, Christopher A},
title = {Patterns of Palliation: A Review of Casualties That Received Pain Management Before Reaching Role 2 in Afghanistan},
journal = {Military Medicine},
year = {2023},
doi = {10.1093/milmed/usac211}
}
EUVIMED